Print ISSN: 2581-4796
Online ISSN: 2581-480X
IP Annals of Prosthodontics and Restorative Dentistry (APRD) open access, peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Review Article
Author Details :
Volume : 4, Issue : 4, Year : 2018
Article Page : 111-113
https://doi.org/10.18231/2581-480X.2018.0029
Abstract
Biomaterials used in implantology have evolved over a period of time. In quest for desirable mechanical, physical and biological properties of material, numerous modifications have been made in existing materials. In order to optimize acceptance of implant in the biologic environment constant efforts have been made to introduce new materials or to improve existing material properties. It is imperative for every clinician to be thorough with the recent advancements and newer biomaterials so as to effectively select a material. For years titanium has ruled over other biomaterials and been used successfully as a dental implant material due to the excellent biocompatibility that it offers. This article makes an effort to summarize various dental implant biomaterials which have been used over a period of time now.
Keywords: Biomaterials, Implantology, Roxolid.
How to cite : Thakur K, Nagpal A, Mayank, Mahajan V , Bhat I A, Biomaterials in implantology: A review. IP Ann Prosthodont Restor Dent 2018;4(4):111-113
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.